SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: TwoBear who wrote (7401)6/6/1999 11:17:00 AM
From: jeffbas  Read Replies (2) | Respond to of 78645
 
TwoBear - NOV has been trading in this price range forever. To what do you attribute the total absence of insider buying? That is an important indicator for me as to whether key people who know the company better than I do share my opinion. Put it another way, there are enough cheap stocks where insiders are buying that I usually avoid the ones where they inexplicably are not.



To: TwoBear who wrote (7401)6/7/1999 12:18:00 AM
From: Michael Burry  Respond to of 78645
 
TwoBear,

A potential benefit to NOV is that one of the head bureacrats, to whom evidently Congress listens, is proposing increases in Medicare outpatient PT reimbursements as well as broadening the PT benefits avaiilable to Medicare. All told, with the aging population, the proven invaluable nature and efficiency of outpatient PT, and possibly a higher percentage of the health care dollar going to PT, it makes things sound a lot better for NOV than a quick look at the finances might seem. It's already doubled off its bottom. I'm still looking at it. At first glance, I held my nose and dismissed it. Now I'm revisiting.

Mike